HPV Infections, Cancer of the Vulva and Therapeutical Success
- Conditions
- Human Papilloma VirusHPV
- Interventions
- Diagnostic Test: polymerase chain reaction
- Registration Number
- NCT03082950
- Lead Sponsor
- University of Luebeck
- Brief Summary
HPV infections may be responsible for different types of cancer in females. Primary Goal of the study was to identify the prevalence of an hpv affiliation in retrospective-prospective analysed cohort of patients who suffer from vulvar cancer and their preinvasive lesions.
- Detailed Description
HPV infections may be responsible for different types of cancer in females. Primary Goal of the study was to identify the prevalence of an hpv affiliation in retrospective-prospective analysed cohort of patients who suffer from vulvar cancer and their preinvasive lesions.
After having retrospectively identified patients with vulvar cancer incl. their preinvasive lesions in the clinical registry the hpv status of the samples is prospectively analyzed using a new multiplex pcr Array. Two Groups are build: patients with hpv associated vulvar cancer and patients with non-hpv associated vulvar cancer.
Then, the rate of patients who respond to radiotherapy within the Groups is analyzed by building Kaplan meier plots according to the patients survival and recurrence rate.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 110
- pts. who suffer from vulvar cancer and their preinvasive lesions
- positive informed consent
- complete set of data
- Treatment in luebeck university
- opposite of above
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 polymerase chain reaction human papilloma Virus (hpv) associated vulvar cancer incl. preinvasive lesions 2 polymerase chain reaction non-human papilloma Virus (hpv) associated vulvar cancer incl. preinvasive lesions
- Primary Outcome Measures
Name Time Method prevalence of hpv infections among pations suffering from vulvar cancer and preinvasive lesions 15yrs
- Secondary Outcome Measures
Name Time Method disease free survival among the groups 15yrs
Trial Locations
- Locations (1)
Luebeck University, Department for obstetrics and gynecology
🇩🇪Luebeck, Schleswig Holstein, Germany